This is an old revision of the document!
McGill Interdisciplinary Initiative in Infection and Immunity
The McGill Interdisciplinary Initiative in Infection and Immunity (MI4) is a Canadian research organization in Montreal, Quebec. It is based out of McGill University.
History
COVID-19
MI4 provided research funding related to COVID-19 through their “MI4 Emergency COVID-19 Research Funding” program.1) In particular, MI4 participated as a funding partner of the Canadian arm of the first randomized control trial (RCT) testing hydroxychloroquine for the post-exposure prevention of COVID-19, led by principal investigator David Boulware, which began on March 17, 2020.2)
Organization
Partners
MI4's partners within McGill include:3)
- Advanced BioImaging Facility (ABIF)
Funding
MI4 received funding for their “MI4 Emergency COVID-19 Research Funding” program through the McGill University Health Centre Foundation COVID-19 Emergency Fund from:4)
Activities
| MI4 Emergency COVID-19 Research Funding5) | |
|---|---|
| MI4 COVID-19 Strategic Funding Grants | |
| Peter Goldberg | The use of volatile anesthetics in COVID-19 intubated patients: A pilot study |
| Vincent Mooser | Extensive and Longitudinal Proteomic Profiling in Plasma from Severe COVID19 Patients |
| Cécile Rousseau, Alexandra de Pokomandy | CanCOVID - COVID‐19 Outreach and Communications for Marginalized Communities in Montreal |
| MI4 ECRF Round 2 | |
| Lead investigators | Project title |
| Nicole Basta | Real-Time Tracking of COVID-19 Vaccine Development |
| Inés Colmegna, Amal Bessissow, David Meger | Use of Technology to Improve Effects of Social Isolation on Hospitalized COVID-19 Patients (TIES-COVID) |
| Gonzalo Cosa | Novel Small Molecule Antiviral Agents for Treatment of SARS-CoV-2 causing COVID 19 coronavirus disease: Target Identification and Structural Optimization |
| Kristian Filion | Anticoagulant treatment and risk of adverse outcomes among hospitalized COVID-19 patients |
| Patricia Fontela, Jesse Papenburg | A Multi-centre, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Children in Canada (CATCO-Kids) |
| Jason Harley, Tina Montreuil | Emotion Regulation and Healthcare Professionals: Creating Research-informed Solutions |
| Lily Hechtman, Philippe Hwang, Lindsay Parr | Factors affecting positive and negative adaptation to quarantine in children and their families during the COVID-19 pandemic |
| Matthew Hunt | Ethical tensions of implementing research during a crisis: Understanding moral experiences of healthcare providers caring for patients who are enrolled in CoViD-19 clinical trials |
| Jonathan Kimmelman | Expert and Lay Perceptions of Translation of COVID19 Treatment and Vaccine Development |
| Jonathan Kimmelman | Success Rate and Timeline for Development of Vaccines for Emerging and Reemerging Viral Infectious Diseases |
| Bertrand Lebouché | Use of OPAL-COVID, a mobile application, for real-time at home follow-up of people who test positive for COVID-19 at the Glen site: a feasibility study |
| Greg Matlashewski, Matthew Cheng, Momar Ndao | Detection of anti- SARS-CoV-2 antibodies in sera from COVID19 patients |
| Momar Ndao, Michael Reed, Martin Olivier | COVID-19 Vaccines - Novel Approaches to Tackle a Novel Disease |
| Janusz Rak, Maziar Divangahi, Dongsic Choi | Exosomal mimetics of COVID-19 as viral models and therapeutics |
| Stéphane Rinfret | Effect of coronavirus pandemic and health care system response on non-COVID-19-related mortality, post pandemic myocardial infarction and heart failure rates in Quebec; a collateral damage in this war? |
| Cécile Rousseau | Health Communication, Sociocultural Diversity, and COVID-19 |
| Selena Sagan, Richard Menzies | Germicidal ultraviolet light to disinfect personal protective equipment to reduce nosocomial transmission of COVID-19 |
| Jonathan Spicer | Evaluating Neutrophil Extracellular Traps as a therapeutic target in COVID-19 patients |
| Brett Thombs, Andrea Benedetti | Mental Health during the COVID-19 Pandemic: A Living Systematic Review of Symptom Levels, Factors Associated with Symptoms, and Intervention Effectiveness |
| David Wachsmuth | A spatial analysis of COVID-19 risk and recovery in Canadian cities |
External links
1)
, 4)
, 5)
Results of MI4 Emergency COVID-19 Research Funding. MI4. Retrieved May 16, 2023, from https://web.archive.org/web/20230516234033/https://www.mcgill.ca/mi4/mi4-supported-research/emergency-covid-19-research-funding
2)
Lofgren, S. M., Nicol, M. R., Bangdiwala, A. S., Pastick, K. A., Okafor, E. C., Skipper, C. P., Pullen, M. F., Engen, N., Abassi, M., Williams, D. A., Nascene, A. A., Axelrod, M. L., Lother, S. A., MacKenzie, L. J., Drobot, G., Marten, N., Cheng, M. P., Zarychanshi, R., Schwartz, I. S., & Silverman, M. J. (2020). Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19. medRxiv. https://doi.org/10.1101/2020.07.16.20155531
3)
McGill Partners. MI4. Retrieved May 16, 2023, from https://web.archive.org/web/20230516232825/https://www.mcgill.ca/mi4/our-people/mcgill-partners